{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:32:06Z","timestamp":1790775126912,"version":"4.1.0"},"reference-count":48,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2003,2,25]],"date-time":"2003-02-25T00:00:00Z","timestamp":1046131200000},"content-version":"vor","delay-in-days":24,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Birth Defects Research"],"published-print":{"date-parts":[[2003,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>BACKGROUND<\/jats:title><jats:p>Treatment of pregnant mice with 2\u2010chloro\u20102\u2032\u2010deoxyadenosine (2CdA) on Day 8 of gestation induces microphthalmia through a mechanism linked to the p53 tumor suppressor pathway. The present study defines the response of Day 8 mouse embryos through time with respect to pharmacologic intervention with PK11195, a ligand of the mitochondrial peripheral benzodiazepine receptor (Bzrp).<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS<\/jats:title><jats:p>Pregnant CD\u20101 mice dosed with 2CdA with or without PK11195 on gestation Day 8 provided fetuses for teratologic evaluation on Day 14 and Day 17; HPLC measured pyridine nucleotides (NADH\/NAD<jats:sup>+<\/jats:sup>) at 1.5 hr, RT\u2010PCR measured mitochondrial 16S rRNA abundance at 3.0 hr, and p53 protein induction was assessed with immunostaining at 4.5 hr postexposure.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>The mean incidences of malformed fetuses were significantly higher in the 7.5 mg\/kg 2CdA treatment group (50.2% malformed) vs. the 2CdA + 4.0 mg\/kg PK11195 co\u2010treatment group (4.4% malformed). Malformed fetuses displayed a range of ocular defects that included microphthalmia and keratolenticular dysgenesis (Peters anomaly). No malformations were observed in the control or PK11195 alone groups. PK11195 also protected litters from increased resorption rates and fetal weight reduction. It did not rescue early effects on NADH balance (1.5 hr) or 16S rRNA expression (3.0 hr); however, the p53 response (4.5 hr) was downgraded in 2CdA + PK11195 embryos vs. 2CdA alone. By delaying the administration of PK11195 in 1.5 hr intervals it was determined that the window for protection closed between 4.5 to 6.0 hr after 2CdA.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS<\/jats:title><jats:p>The capacity of PK11195 to suppress the pathogenesis of microphthalmia implies a critical role for mitochondrial peripheral benzodiazepine receptors in the p53\u2010dependent mode of action of 2CdA on ocular development. Birth Defects Research (Part A) 67:108\u2013115, 2003. \u00a9 2003 Wiley\u2010Liss, Inc.<\/jats:p><\/jats:sec>","DOI":"10.1002\/bdra.10026","type":"journal-article","created":{"date-parts":[[2003,3,18]],"date-time":"2003-03-18T23:09:00Z","timestamp":1048028940000},"page":"108-115","source":"Crossref","is-referenced-by-count":15,"title":["Exposure\u2010disease continuum for 2\u2010chloro\u20102\u2032\u2010deoxyadenosine, a prototype ocular teratogen. 3. Intervention with PK11195"],"prefix":"10.1002","volume":"67","author":[{"given":"Jeffrey H.","family":"Charlap","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald J.","family":"Donahue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas B.","family":"Knudsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2003,2,25]]},"reference":[{"key":"e_1_2_6_2_1","first-page":"517","article-title":"Peripheral\u2010type benzodiazepine receptors: autoradiographic localization in whole\u2010body sections of neonatal rats","volume":"233","author":"Anholt RRH","year":"1985","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_6_3_1","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0021-9258(17)36131-8","article-title":"The peripheral\u2010type benzodiazepine receptor. Localization to the outer mitochondrial membrane","volume":"261","author":"Anholt RRH","year":"1986","journal-title":"J Biol Chem"},{"key":"e_1_2_6_4_1","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1242\/dev.124.16.3089","article-title":"Genetically engineered mice demonstrate that adenosine deaminase is essential for early postimplantation development","volume":"124","author":"Blackburn MR","year":"1997","journal-title":"Development"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1999.1683"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2826.1999.00292.x"},{"key":"e_1_2_6_7_1","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1182\/blood.V87.8.3170.bloodjournal8783170","article-title":"Involvement of peripheral benzodiazepine receptors in the protection of hematopoietic cells against oxygen radical damage","volume":"87","author":"Carayon P","year":"1996","journal-title":"Blood"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/0065-2571(88)90028-3"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0197-0186(01)00118-8"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.2.655"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1006\/abbi.1993.1175"},{"key":"e_1_2_6_12_1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3928\/0191-3913-19880301-04","article-title":"Keratolenticular dysgenesis (Peters' anomaly) as a result of acute embryonic insult during gastrulation","volume":"25","author":"Cook CS","year":"1988","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1010812128765"},{"key":"e_1_2_6_14_1","first-page":"1388","article-title":"Peripheral benzodiazepine receptor ligands reverse apoptosis resistance of cancer cells in vitro and in vivo","volume":"62","author":"Decaudin D","year":"2002","journal-title":"Cancer Res"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(99)00439-9"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.00-0262com"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0320(19960501)24:1<39::AID-CYTO5>3.0.CO;2-D"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/tera.1420490103"},{"key":"e_1_2_6_19_1","first-page":"69","article-title":"Bcl\u20102 relieves deoxyadenylate stress and suppress apoptosis in pre\u2010B leukemia cells","volume":"2","author":"Gao X","year":"1995","journal-title":"Cell Death Differ"},{"key":"e_1_2_6_20_1","first-page":"201","article-title":"In vitro reconstitution of a functional peripheral\u2010type benzodiazepine receptor from mouse Leydig tumor cells","volume":"45","author":"Garnier M","year":"1994","journal-title":"Mol Pharmacol"},{"key":"e_1_2_6_21_1","first-page":"629","article-title":"Enigma of the peripheral benzodiazepine receptor","volume":"51","author":"Gavish M","year":"1999","journal-title":"Pharmacol Rev"},{"key":"e_1_2_6_22_1","first-page":"955","article-title":"Template 2\u2010chloro\u20102\u2032\u2010deoxyadenosine monophosphate inhibits in vitro DNA synthesis","volume":"45","author":"Hentosh P","year":"1994","journal-title":"Mol Pharmacol"},{"key":"e_1_2_6_23_1","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1124\/mol.51.4.613","article-title":"2\u2010Chloro\u20102\u2032\u2010deoxyadenosine, an antileukemic drug, has an early effect on cellular mitochondrial function","volume":"51","author":"Hentosh P","year":"1997","journal-title":"Mol Pharmacol"},{"key":"e_1_2_6_24_1","first-page":"164","article-title":"Characterization of ligand binding to mitochondrial benzodiazepine receptors","volume":"34","author":"Hirsch JD","year":"1988","journal-title":"Mol Pharmacol"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1006\/excr.1998.4084"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-4889(98)00066-4"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.22.11941"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1432-1327.2000.01607.x"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/tera.1420450109"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/tera.10039"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(83)90062-0"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.16.9567"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199732020-00003"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1159\/000056091"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/tera.10028"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.51.32129"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.47.29792"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600740916"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.490300303"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.jbchem.a124790"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.84.8.2256"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1006\/phrs.1999.0617"},{"key":"e_1_2_6_43_1","doi-asserted-by":"crossref","first-page":"22847","DOI":"10.1016\/S0021-9258(18)41605-5","article-title":"Substrate specificity of mitochondrial 2\u2032\u2010deoxyadenosine kinase: efficient phosphorylation of 2\u2010chlorodeoxyadenosine","volume":"268","author":"Wang L","year":"1993","journal-title":"J Biol Chem"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(96)00623-0"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1006\/excr.1998.4331"},{"key":"e_1_2_6_46_1","unstructured":"WubahJA.1998.A model for p53 gene\u2010teratogen interaction in early mouse embryos. PhD thesis. Thomas Jefferson University Philadelphia PA."},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-9822(02)00422-0"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1002\/tera.1059"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.24.14707"}],"container-title":["Birth Defects Research Part A: Clinical and Molecular Teratology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/bdra.10026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T17:25:55Z","timestamp":1700155555000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/bdra.10026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,2]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,2]]}},"alternative-id":["10.1002\/bdra.10026"],"URL":"https:\/\/doi.org\/10.1002\/bdra.10026","archive":["Portico"],"relation":{},"ISSN":["1542-0752","1542-0760"],"issn-type":[{"value":"1542-0752","type":"print"},{"value":"1542-0760","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,2]]}}}